Documents
Application Sponsors
ANDA 076217 | MYLAN INSTITUTIONAL | |
Marketing Status
Application Products
001 | INJECTABLE;INJECTION | 50MG/ML | 0 | AMIODARONE HYDROCHLORIDE | AMIODARONE HYDROCHLORIDE |
FDA Submissions
| ORIG | 1 | AP | 2002-10-15 | |
LABELING; Labeling | SUPPL | 3 | AP | 2003-11-14 | |
LABELING; Labeling | SUPPL | 5 | AP | 2004-01-05 | |
LABELING; Labeling | SUPPL | 11 | AP | 2006-02-01 | |
LABELING; Labeling | SUPPL | 12 | AP | 2007-10-15 | |
LABELING; Labeling | SUPPL | 13 | AP | 2008-03-24 | |
LABELING; Labeling | SUPPL | 17 | AP | 2009-06-24 | |
LABELING; Labeling | SUPPL | 33 | AP | 2020-06-23 | STANDARD |
Submissions Property Types
TE Codes
CDER Filings
MYLAN INSTITUTIONAL
cder:Array
(
[0] => Array
(
[ApplNo] => 76217
[companyName] => MYLAN INSTITUTIONAL
[docInserts] => ["",""]
[products] => [{"drugName":"AMIODARONE HYDROCHLORIDE","activeIngredients":"AMIODARONE HYDROCHLORIDE","strength":"50MG\/ML","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"","rld":"No","rs":"Yes"}]
[labels] =>
[originalApprovals] => [{"actionDate":"AMIODARONE HYDROCHLORIDE","submission":"AMIODARONE HYDROCHLORIDE","actionType":"50MG\/ML","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)